Usefulness of Vernakalant Hydrochloride Injection for Rapid Conversion of Atrial Fibrillation

Autor: Christian Torp-Pedersen, D. George Wyse, David Humphrey Drenning, Enrique Retyk, Egon Toft, Steen Juul-Möller, Craig M. Pratt, Dennis Roy

Publikováno v: Pratt, C M, Roy, D, Torp-Pedersen, C, Wyse, D G, Toft, E, Juul-Moller, S, Retyk, E & Drenning, D H 2010, ' Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation ', American Journal of Cardiology, vol. 106, no. 9, pp. 1277-1283 . https://doi.org/10.1016/j.amjcard.2010.06.054

The objective of the present study was to assess the safety and effectiveness of vernakalant hydrochloride injection (RSD1235), a novel antiarrhythmic drug, for the conversion of atrial fibrillation (AF) or atrial flutter to sinus rhythm (SR). Patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5041c5dde01c55f3720608e86294a20
https://doi.org/10.1016/j.amjcard.2010.06.054